Journal of Shandong University (Health Sciences) ›› 2020, Vol. 58 ›› Issue (1): 73-76.doi: 10.6040/j.issn.1671-7554.0.2019.1160

Previous Articles    

Diagnosis and treatment of matanephric adenoma: a single center experience

LEI Kunyang1, WANG Xu2, MA Ming1, SUN Ting1   

  1. 1. Department of Urology;
    2. Department of Pathology, The First Affiliated Hospital of Nanchang University, Nanchang 330000, Jiangxi, China
  • Published:2022-09-27

PDF (PC)

16

Abstract: Objective To explore the clinical manifestations, imaging features, pathological features, treatment and prognosis of metanephric adenoma(MA)in order to improve the diagnosis and treatment of MA. Methods The clinical data of 9 MA patients confirmed by pathology in The First Affiliated Hospital of Nanchang University from May 2011 to January 2019 were analyzed retrospectively, and their clinical manifestations, imaging characteristics, histological and immunohistochemical characteristics, treatment methods and prognosis were summarized, analyzed and discussed. Results A total of 9 MA patients were enroued in this study, including 1 case of low back pain, 2 cases of low back discomfort, 1 case of low back pain complicated with polycythemia, and the other 5 cases were found by physical examination. The tumors were located on the left side in 5 cases and on the right side in 4 cases. The mean diameter of the tumors was 4.3(1.7-6.7)cm. Laparoscopic partial nephrectomy(LPN)was performed in 7 cases and laparoscopic radical nephrectomy(LRN)in 2 cases. All cases were pathologically diagnosed as MA. The mean follow-up time was 43(5-97)months, and there were no recurrence or metastasis in all cases. Conclusion MA is a rare renal tumor. Its clinical manifestations and imaging features are helpful for diagnosis, but the diagnosis mainly depends on pathology. The prognosis of MA is generally good, but regular follow-up is needed.

Key words: Matanephric adenoma, Pathology, Diagnosis, Treatment

CLC Number: 

  • R602
[1] Wang P, Tian Y, Xiao Y, et al. A metanephric adenoma of the kidney associated with polycythemia: a case report[J]. Oncol Lett, 2016, 11(1): 352-354.
[2] Moch H, Cubilla AL, Humphrey PA, et al. The 2016 WHO classification of tumours of the urinary system and male genital organs-part A: renal, penile, and testicular tumours[J]. Eur Urol, 2016, 70(1): 93-105.
[3] Kuroda N, Tol M, Hiroi M, et al. Review of metanephric adenoma of the kidney with focus on clinical and pathobiological aspects[J]. Histol Histopathol, 2003, 18(1): 253-257.
[4] Bove KE, Bhathena D, Wyatt RJ, et al. Diffuse metanephric adenoma after in utero aspirin intoxication. A unique case of progressive renal failure[J]. Arch Pathol Lab Med, 1979, 103(4): 187-190.
[5] Brisigotti M, Cozzutto C, Fabbretti G, et al. Metanephric adenoma[J]. Histol Histopathol, 1992, 7(4): 689-692.
[6] Davis CJ, Barton JH, Sesterhenn IA, et al. Metanephric adenoma. Clinicopathological study of fifty patients[J]. Am J Surg Pathol, 1995, 19(10): 1101-1114.
[7] Jones EC, Pins M, Dickersin GR, et al. Metanephric adenoma of the kidney. A clinicopathological, immunohistochemical, flow cytometric, cytogenetic, and electron microscopic study of seven cases[J]. Am J Surg Pathol, 1995, 19(6): 615-626.
[8] Yoshioka K, Miyakawa A, Ohno Y, et al. Production of erythropoietin and multiple cytokines by metanephric adenoma results in erythrocytosis[J]. Pathol Int, 2007, 57(8): 529-536.
[9] Dusan R, Relja K, Marija M, et al. A case of metanephric adenoma and acute myocardial infarction[J]. Acta Cardiol Sin, 2016, 32(4): 502-505.
[10] Zhang LJ, Yang GF, Shen W, et al. CT and ultrasound findings of metanephric adenoma: a report of two cases and literature review[J]. Br J Radiol, 2011, 84(999): e51-e54. doi: 10.1259/bjr/62994226.
[11] Zambrano N, Vivaldi B, Espinoza R. [Metanephric adenoma of the kidney associated with polycythemia and erythromelalgia: report of one case] [J]. Rev Med Chil, 2012, 140(5): 629-632.
[12] Yan J, Cheng JL, Li CF, et al. The findings of CT and MRI in patients with metanephric adenoma[J]. Diagn Pathol, 2016, 11(1):104.
[13] Jiang T, Li W, Lin D, et al. Imaging features of metanephric adenoma and their pathological correlation[J]. Clin Radiol, 2019, 74(5): 408-409.
[14] Sun Z, Kan S, Zhang L, et al. Immunohistochemical phenotype and molecular pathological characteristics of metanephric adenoma[J]. Int J Clin Exp Pathol, 2015, 8(6): 6031-6036.
[15] 席晨光, 范宇, 杨新宇, 等. 16例后肾腺瘤的临床病理特点及鉴别诊断[J]. 北京大学学报(医学版), 2016, 48(4): 598-602. XI Chenguang, FAN Yu, YANG Xinyu, et al. Clinicopathological features and differential diagnosis of metanephric adenoma: a report of sixteen cases[J]. Journal of Peking University(Health Sciences), 2016, 48(4): 598-602.
[16] Yakirevich E, Magi-Galluzzi C, Grada Z, et al. Cadherin 17 is a sensitive and specific marker for metanephric adenoma[J]. Am J Surg Pathol, 2015, 39(4): 479-486.
[17] Azabdaftari G, Alroy J, Banner BF, et al. S100 protein expression distinguishes metanephric adenomas from other renal neoplasms[J]. Pathol Res Pract, 2008, 204(10): 719-723.
[18] Olgac S, Hutchinson B, Tickoo SK, et al. Alpha-methylacyl-CoA racemase as a marker in the differential diagnosis of metanephric adenoma[J]. Mod Pathol, 2006, 19(2): 218-224.
[19] Kinney SN, Eble JN, Hes O, et al. Metanephric adenoma: the utility of immunohistochemical and cytogenetic analyses in differential diagnosis, including solid variant papillary renal cell carcinoma and epithelial-predominant nephroblastoma[J]. Mod Pathol, 2015, 28(9): 1236-1248.
[20] Le Nué R, Marcellin L, Ripepi M, et al. Conservative treatment of metanephric adenoma. A case report and review of the literature[J]. J Pediatr Urol, 2011, 7(4): 399-403.
[21] Delzongle M, Boukamel S, Kemeny F, et al. Metanephric adenoma: MR imaging features with histopathological correlation[J]. Diagn Interv Imaging, 2015, 96(4): 387-390.
[22] Drut R, Drut RM, Ortolani C. Metastatic metanephric adenoma with foci of papillary carcinoma in a child: a combined histologic, immunohistochemical, and FISH study[J]. Int J Surg Pathol, 2001, 9(3): 241-247.
[1] ZHAO Li-Xing, SONG Dai-Hui, WEI Kui-Jie, YIN Kai. An animal model of osteoarthritis on the temporomandibular joint [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 25-27.
[2] LV Yan-Feng, DING Ke, WANG Jian-Xin, YU Hua-Long, BEI Shao-Sheng. Canceration of chronic anal fistula [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 55-57.
[3] LI Bo-Bo, LI Dao-Tang, LIU Shu-Guang, WANG Xing-Wu. Expression of serum DKK-1 in esophageal cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 58-61.
[4] XU Ping, YU Guo-Fang, LI Xia. Differential diagnosis of Graves′ disease and Hashimoto′s thyroiditis by different types peak systolic velocity of the superior thyroid artery [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 62-64.
[5] WANG Xin, XING Chun-Yan, YANG Yan-Ping. Serum phosphopyruvate hydratase in diagnosis of invasive Candida albicans infection [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 92-94.
[6] WANG Lihui, GAO Min, KONG Beihua. Angiosarcoma of the uterus: a report of 2 cases and literature review [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 108-112.
[7] JIANG Ziqing, ZENG Yanping, JI Xiaodong, ZUO Junling. A case report of hemophagocytic syndrome secondary to talaromyces marneffei infection [J]. Journal of Shandong University (Health Sciences), 2022, 60(8): 91-97.
[8] Chao PENG,Yingfang ZHOU. Progress on the medical treatment of adenomyosis [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 20-25.
[9] ZHANG Jingliang, LIU Xinyu, YUAN Suomao, WANG Lianlei. Causes of misdiagnosis and mistreatment of lumbar degenerative diseases complicated with hip joint diseases(hip-spine syndrome) [J]. Journal of Shandong University (Health Sciences), 2022, 60(5): 67-73.
[10] SONG Min, ZHOU Yuxia, GAO Lu, LIU Na, WANG Ju, GU Jin, ZHANG Yanping. Prenatal diagnosis for a fetus of mosaic trisomy 6q [J]. Journal of Shandong University (Health Sciences), 2022, 60(5): 109-113.
[11] KONG Xinxin, SUN Shuzhen, LI Qian, CHEN Yuan, ZHOU Aihua, WANG Li, YAO Xiujun. Analysis of 7 cases of anti-H factor antibody-positive hemolytic uremic syndrome [J]. Journal of Shandong University (Health Sciences), 2022, 60(4): 82-86.
[12] ZUO Liping, JIANG Fengyang, ZHOU Binbin, FAN Jinlei, LIANG Yongfeng, DENG Zhanhao, YU Dexin. Value of preoperative multiphase MRI for predicting microvascular invasion and early recurrence of 169 hepatocellular carcinoma [J]. Journal of Shandong University (Health Sciences), 2022, 60(3): 89-95.
[13] SONG Yufeng, NING Hao, YAO Zhigang, WU Haihu, LIU Feifan, LYU Jiaju. Clinical and imaging features of adrenal cavernous hemangioma [J]. Journal of Shandong University (Health Sciences), 2022, 60(2): 37-42.
[14] PAN Pengfei, XU Lisheng, JI Kunqian, WANG Dexiang, LI Yu. Mitochondrial myopathy beginning with respiratory failure: one case and literature review [J]. Journal of Shandong University (Health Sciences), 2022, 60(2): 54-59.
[15] LI Yan, LIU Jing, LI Juan, YANG Qiuhong. Clinical characteristics and placental pathology of bloodstream infection in 50 pregnant women [J]. Journal of Shandong University (Health Sciences), 2022, 60(1): 48-54.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd